{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:46:44Z","timestamp":1775818004943,"version":"3.50.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mrm.0b013e3283587727","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T06:58:29Z","timestamp":1349765909000},"page":"7-17","source":"Crossref","is-referenced-by-count":172,"title":["\u03b2-Lactams"],"prefix":"10.1097","volume":"24","author":[{"given":"R\u00faben","family":"Fernandes","sequence":"first","affiliation":[]},{"given":"Paula","family":"Amador","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Prud\u00eancio","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R2-2-20210126","first-page":"496","article-title":"Are antibiotics naturally antibiotics J Ind Microbiol B","volume":"33","author":"Davies","year":"2006","journal-title":"iotech"},{"key":"R3-2-20210126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijmm.2006.01.039","article-title":"The truth about antibiotics.","volume":"296","author":"Yim","year":"2006","journal-title":"Int J Med Microbiol"},{"key":"R4-2-20210126","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. Influenzae.","volume":"10","author":"Fleming","year":"1929","journal-title":"Br J Exp Pathol"},{"key":"R6-2-20210126","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1021\/bi047478q","article-title":"Structural studies on the reaction of isopenicillin N synthase with the truncated substrate analogues delta-(L-alpha-aminoadipoyl)-L-cysteinyl-glycine and delta-(L-alpha-aminoadipoyl)-L-cysteinyl-D-alanine.","volume":"44","author":"Long","year":"2005","journal-title":"Biochemistry"},{"key":"R7-2-20210126","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0190-9622(96)90729-X","article-title":"Penicillamine-induced bullous dermatoses.","volume":"35","author":"Bialy-Golan","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R8-2-20210126","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum -lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"R9-2-20210126","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1749-6632.1967.tb50220.x","article-title":"The chemistry of synthetic and semisynthetic penicillins.","volume":"145","author":"Sheehan","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"R10-2-20210126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/0929867305666220319110127","article-title":"-Lactamase inhibitors: agents to overcome bacterial resistance.","volume":"5","author":"Maiti","year":"1998","journal-title":"Curr Med Chem"},{"key":"R11-2-20210126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2222.2007.02867.x","article-title":"Oral challenges are needed in the diagnosis of -lactam hypersensitivity.","volume":"38","author":"Bousquet","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"R12-2-20210126","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000070616","article-title":"The art of fusion: from penams and cephems to penems.","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"R14-2-20210126","first-page":"175548","article-title":"Cephalosporin C, a new antibiotic containing sulphur and D-alpha-aminoadipic acid.","volume":"26","author":"Newton","year":"1995","journal-title":"Nature"},{"key":"R15-2-20210126","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/78467","article-title":"Environmentally safe production of 7-aminodeacetoxycephalosporanic acid (7-ADCA) using recombinant strains of Acremonium chrysogenum.","volume":"18","author":"Velasco","year":"2000","journal-title":"Nat Biotechnol"},{"key":"R16-2-20210126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11882-008-0010-1","article-title":"Antibiotic allergy: immunochemical and clinical considerations.","volume":"8","author":"Baldo","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"R17-2-20210126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/14728214.12.4.511","article-title":"Emerging cephalosporins.","volume":"12","author":"Page","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"R18-2-20210126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.39.2.533","article-title":"Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.","volume":"39","author":"Fung-Tomc","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-2-20210126","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2146\/ajhp070435","article-title":"Influence of extended-spectrum -lactams on Gram-negative bacterial resistance.","volume":"65","author":"Paladino","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"R21-2-20210126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jac\/dki462","article-title":"Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy.","volume":"57","author":"ONeill","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R22-2-20210126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.diagmicrobio.2008.02.008","article-title":"Antimicrobial activity of ceftobiprole, a novel antimethicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).","volume":"61","author":"Fritsche","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R23-2-20210126","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.","volume":"39","author":"Gould","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"R24-2-20210126","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/AAC.01452-08","article-title":"In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including -lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.","volume":"53","author":"Vidaillac","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-2-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1389557043487501","article-title":"-Lactams in the new millennium. Part-I: Monobactams and carbapenems.","volume":"4","author":"Singh","year":"2004","journal-title":"Mini Rev Med Chem"},{"issue":"Suppl A","key":"R26-2-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/31.suppl_A.1","article-title":"Meeting the challenges of -lactamases.","volume":"31","author":"Moellering","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"R28-2-20210126","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular mechanisms that confer antibacterial drug resistance.","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"key":"R29-2-20210126","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"-Lactamases in laboratory and clinical resistance.","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"R30-2-20210126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10495390600957092","article-title":"Genetics of antimicrobial resistance.","volume":"17","author":"Harbottle","year":"2006","journal-title":"Anim Biotechnol"},{"key":"R31-2-20210126","first-page":"489","article-title":"Carbapenemases: a problem in waiting Curr Opin M","volume":"3","author":"Livermore","year":"2000","journal-title":"icrobiol"},{"key":"R32-2-20210126","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for -lactamases and its correlation with molecular structure.","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-2-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of -lactamases.","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos Trans R Soc London Ser B"},{"key":"R34-2-20210126","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0006-2952(94)00502-D","article-title":"The enigmatic catalytic mechanism of active-site serine -lactamases.","volume":"49","author":"Galleni","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"R36-2-20210126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/44.3.309","article-title":"Evolution and spread of SHV extended-spectrum -lactamases in Gram-negative bacteria.","volume":"44","author":"Heritage","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R37-2-20210126","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.327.7425.1209","article-title":"Recent developments in -lactamases and extended-spectrum -lactamases.","volume":"327","author":"Samaha-Kfoury","year":"2003","journal-title":"BMJ"},{"key":"R38-2-20210126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajic.2004.07.010","article-title":"Extended-spectrum -lactamases: a challenge for clinical microbiologists and infection control specialists.","volume":"33","author":"Colodner","year":"2005","journal-title":"Am J Infect Control"},{"key":"R39-2-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended-spectrum -lactamases: the CTX-M enzymes.","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-2-20210126","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M -lactamase pandemic.","volume":"9","author":"Canton","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"R41-2-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1139\/w03-111","article-title":"Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum -lactamases.","volume":"50","author":"Walther-Rasmussen","year":"2004","journal-title":"Can J Microbiol"},{"key":"R42-2-20210126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum -lactamases (ESBLs) in the community.","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R43-2-20210126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.48.2.533-537.2004","article-title":"Epidemiology of conjugative plasmid-mediated AmpC -lactamases in the United States.","volume":"48","author":"Alvarez","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R44-2-20210126","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(00)81928-5","article-title":"Cytosolic intermediates for cell wall biosynthesis and degradation control inducible -lactam resistance in Gram-negative bacteria.","volume":"88","author":"Jacobs","year":"1997","journal-title":"Cell"},{"key":"R45-2-20210126","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(05)75707-X","article-title":"Worldwide proliferation of carbapenem-resistant Gram-negative bacteria.","volume":"354","author":"Kurokawa","year":"1999","journal-title":"Lancet"},{"key":"R46-2-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/labinvest.3700501","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.","volume":"87","author":"Boyle-Vavra","year":"2007","journal-title":"Lab Invest"},{"key":"R47-2-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/533591","article-title":"Pathogenesis of methicillin-resistant Staphylococcus aureus infection.","volume":"46","author":"Gordon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R48-2-20210126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0968-0004(94)90204-6","article-title":"Multidrug resistance pumps in bacteria: variations on a theme.","volume":"19","author":"Lewis","year":"1994","journal-title":"Trends Biochem Sci"},{"key":"R49-2-20210126","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2958.1999.01162.x","article-title":"The multidrug efflux protein NorM is a prototype of a new family of transporters.","volume":"31","author":"Brown","year":"1999","journal-title":"Mol Microbiol"},{"key":"R50-2-20210126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/JB.186.1.262-265.2004","article-title":"An H-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa.","volume":"186","author":"He","year":"2004","journal-title":"J Bacteriol"},{"key":"R51-2-20210126","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism.","volume":"47","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"R52-2-20210126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389450023347588","article-title":"Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.","volume":"3","author":"Perez-Victoria","year":"2002","journal-title":"Curr Drug Targets"},{"key":"R53-2-20210126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/JB.178.1.306-308.1996","article-title":"AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.","volume":"178","author":"Okusu","year":"1996","journal-title":"J Bacteriol"},{"key":"R54-2-20210126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2958.2000.01926.x","article-title":"Multidrug resistance mechanisms: drug efflux across two membranes.","volume":"37","author":"Zgurskaya","year":"2000","journal-title":"Mol Microbiol"},{"key":"R55-2-20210126","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1128\/JB.170.12.5416-5422.1988","article-title":"marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli.","volume":"170","author":"Cohen","year":"1988","journal-title":"J Bacteriol"},{"key":"R56-2-20210126","doi-asserted-by":"crossref","first-page":"24245","DOI":"10.1074\/jbc.M804544200","article-title":"AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals.","volume":"283","author":"Nikaido","year":"2008","journal-title":"J Biol Chem"},{"key":"R57-2-20210126","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00203-003-0592-x","article-title":"The acrAB locus is involved in modulating intracellular acetyl coenzyme A levels in a strain of Escherichia coli CM2555 expressing the chloramphenicol acetyltransferase (cat) gene.","volume":"180","author":"Potrykus","year":"2003","journal-title":"Arch Microbiol"},{"key":"R58-2-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jac\/dkm397","article-title":"MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.","volume":"61","author":"Keeney","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R59-2-20210126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/AAC.42.2.399","article-title":"-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.","volume":"42","author":"Li","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R60-2-20210126","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/00365540310014639","article-title":"Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli.","volume":"35","author":"Kallman","year":"2003","journal-title":"Scand J Infect Dis"}],"container-title":["Reviews in Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00013542-201301000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:11:03Z","timestamp":1714450263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00013542-201301000-00002"}},"subtitle":["chemical structure, mode of action and mechanisms of resistance"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mrm.0b013e3283587727","relation":{},"ISSN":["0954-139X"],"issn-type":[{"value":"0954-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}